AMGN in the 13F filings
Amgen Inc · CUSIP 031162100
- Quarter end
- 30 Jun 2025
- the date the book describes
- Filed
- 27 Oct 2026
- latest of these filings; the earliest 30 Jul 2025
- Managers listing it
- 20
- at least, of 95 tracked, among listed positions
- Comparable managers
- 95
- filed both Q1 2025 and Q2 2025; 17 listed it in both
- Shares listed
- 36,629,737
- combined, among listed positions
- Reported value
- $10.2bn
- combined, at the quarter end
Among the 95 comparable managers: 13 buyers (opened or added shares) and 8 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.
Managers listing AMGN in Q2 2025
20 of 20 holders
Largest increases and reductions, by shares
Increases
- Janus Henderson Group Ltdexisting position · 2,884,935 shares now+342,446
- Invesco Ltdexisting position · 4,190,256 shares now+339,755
- Arrowstreet Capital LPnew position · 214,305 shares now+214,305
- Renaissance Technologies LLCexisting position · 277,300 shares now+162,900
- Capital World Investorsexisting position · 16,859,598 shares now+157,989
Reductions
- T. Rowe Price Associates Incexisting position · 1,142,525 shares now-895,054
- D. E. Shaw & Co.existing position · 625,081 shares now-635,803
- Fidelity (FMR LLC)existing position · 3,668,288 shares now-210,387
- Woodline Partners LPexisting position · 183,416 shares now-176,223
- AllianceBernstein LPexisting position · 1,039,390 shares now-11,170
New positions and exits
New (2)
Exited (1)
- Marshall Wace LLPwas $56m
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2013 | 21 | $17.1bn | n.a. | n.a. |
| Q3 2013 | 19 | $19.1bn | n.a. | n.a. |
| Q4 2013 | 22 | $19.9bn | n.a. | n.a. |
| Q1 2014 | 17 | $22.0bn | n.a. | n.a. |
| Q2 2014 | 24 | $20.5bn | n.a. | n.a. |
| Q3 2014 | 27 | $24.1bn | n.a. | n.a. |
| Q4 2014 | 24 | $28.1bn | n.a. | n.a. |
| Q1 2015 | 26 | $28.3bn | n.a. | n.a. |
| Q2 2015 | 28 | $26.3bn | n.a. | n.a. |
| Q3 2015 | 32 | $23.9bn | n.a. | n.a. |
| Q4 2015 | 31 | $27.5bn | n.a. | n.a. |
| Q1 2016 | 29 | $24.2bn | n.a. | n.a. |
| Q2 2016 | 28 | $23.0bn | n.a. | n.a. |
| Q3 2016 | 31 | $24.6bn | n.a. | n.a. |
| Q4 2016 | 25 | $20.3bn | n.a. | n.a. |
| Q1 2017 | 31 | $23.4bn | n.a. | n.a. |
| Q2 2017 | 25 | $25.2bn | n.a. | n.a. |
| Q3 2017 | 25 | $27.3bn | n.a. | n.a. |
| Q4 2017 | 26 | $24.5bn | n.a. | n.a. |
| Q1 2018 | 24 | $20.4bn | n.a. | n.a. |
| Q2 2018 | 20 | $26.9bn | n.a. | n.a. |
| Q3 2018 | 19 | $21.2bn | n.a. | n.a. |
| Q4 2018 | 20 | $18.9bn | n.a. | n.a. |
| Q1 2019 | 28 | $17.0bn | n.a. | n.a. |
| Q2 2019 | 22 | $14.5bn | n.a. | n.a. |
| Q3 2019 | 26 | $16.4bn | n.a. | n.a. |
| Q4 2019 | 21 | $18.7bn | n.a. | n.a. |
| Q1 2020 | 21 | $14.2bn | n.a. | n.a. |
| Q2 2020 | 20 | $16.2bn | n.a. | n.a. |
| Q3 2020 | 16 | $16.3bn | n.a. | n.a. |
| Q4 2020 | 19 | $14.0bn | n.a. | n.a. |
| Q1 2021 | 16 | $14.5bn | n.a. | n.a. |
| Q2 2021 | 23 | $13.8bn | n.a. | n.a. |
| Q3 2021 | 24 | $11.6bn | n.a. | n.a. |
| Q4 2021 | 21 | $10.4bn | n.a. | n.a. |
| Q1 2022 | 23 | $9.9bn | n.a. | n.a. |
| Q2 2022 | 28 | $9.7bn | n.a. | n.a. |
| Q3 2022 | 21 | $7.9bn | n.a. | n.a. |
| Q4 2022 | 24 | $9.3bn | n.a. | n.a. |
| Q1 2023 | 22 | $8.4bn | n.a. | n.a. |
| Q2 2023 | 26 | $7.4bn | n.a. | n.a. |
| Q3 2023 | 26 | $8.7bn | n.a. | n.a. |
| Q4 2023 | 24 | $8.4bn | 14 | 11 |
| Q1 2024 | 25 | $6.7bn | 10 | 15 |
| Q2 2024 | 20 | $8.0bn | 11 | 9 |
| Q3 2024 | 21 | $8.8bn | 16 | 5 |
| Q4 2024 | 20 | $8.2bn | 13 | 7 |
| Q1 2025 | 25 | $12.0bn | 10 | 16 |
| Q2 2025 | 20 | $10.2bn | 13 | 8 |
| Q3 2025 | 17 | $10.4bn | 8 | 9 |
| Q4 2025 | 19 | $18.0bn | 13 | 22 |
| Q1 2026 | 15 | $21.4bn | 17 | 15 |
| Q2 2026 | 23 | $24.9bn | 19 | 13 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
AMGN and GILD →AMGN and ARGX →AMGN and RVMD →Choose a stock to compare with AMGN →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own AMGN, latest filings →Back to the 13F Explorer →